FLASH Particle Radiotherapy

FLASH radiotherapy is an emerging treatment modality characterized by the ultrahigh dose rate delivery of radiation, which has demonstrated the potential to significantly reduce normal tissue toxicity while maintaining tumor control. In cancers traditionally managed with radiotherapy, this approach could improve the therapeutic ratio by mitigating severe side effects associated with current techniques. The integration of particle therapy-such as protons or heavier ions-with FLASH dose rates offers unique physical and biological advantages, including enhanced normal tissue sparing and the possibility of safe dose escalation. Clinical implementation will require a deeper understanding of the mechanistic biological underpinnings of the FLASH effect, alongside advancements in beam delivery systems capable of achieving FLASH dose rates, rigorous quality assurance protocols, and adaptive strategies to accommodate anatomic changes during treatment. Ultimately, widespread clinical adoption will depend on prospective trials comparing FLASH particle therapy with established modalities, with endpoints focused on toxicity, disease control, and patient-reported quality of life.

Authors

Institutions

Publication Details

Journal
The Cancer Journal
Published
2026-03-01
DOI
https://doi.org/10.1097/ppo.0000000000000816
Primary Topic
Radiation Therapy and Dosimetry
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

FLASH Particle Radiotherapy

Jufri Setianegara, Constantinos Koumenis, Alexander Lin, Boon-Keng Kevin Teo et al.
The Cancer Journal
Radiation Therapy and Dosimetry
article

FLASH Particle Radiotherapy

Jufri Setianegara, Constantinos Koumenis, Alexander Lin, Boon-Keng Kevin Teo, Ioannis I. Verginadis
article en

Abstract

FLASH radiotherapy is an emerging treatment modality characterized by the ultrahigh dose rate delivery of radiation, which has demonstrated the potential to significantly reduce normal tissue toxicity while maintaining tumor control. In cancers traditionally managed with radiotherapy, this approach could improve the therapeutic ratio by mitigating severe side effects associated with current techniques. The integration of particle therapy-such as protons or heavier ions-with FLASH dose rates offers unique physical and biological advantages, including enhanced normal tissue sparing and the possibility of safe dose escalation. Clinical implementation will require a deeper understanding of the mechanistic biological underpinnings of the FLASH effect, alongside advancements in beam delivery systems capable of achieving FLASH dose rates, rigorous quality assurance protocols, and adaptive strategies to accommodate anatomic changes during treatment. Ultimately, widespread clinical adoption will depend on prospective trials comparing FLASH particle therapy with established modalities, with endpoints focused on toxicity, disease control, and patient-reported quality of life.

The Cancer JournalVol. 32(2)
University of Pennsylvania (US)
Openalex Percentile: Top 9%
Radiation Therapy and Dosimetry
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.